We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $19.8B
1-Year Est. Return 31.12%
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
+31.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.08B
AUM Growth
+$2.81B
Cap. Flow
+$1.98B
Cap. Flow %
24.56%
Top 10 Hldgs %
37.62%
Holding
626
New
29
Increased
518
Reduced
47
Closed
10

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$142M
2
NVDA icon
NVIDIA
NVDA
+$132M
3
AAPL icon
Apple
AAPL
+$124M
4
AMZN icon
Amazon
AMZN
+$77.2M
5
AVGO icon
Broadcom
AVGO
+$68.1M

Sector Composition

Rank Sector Weight
1 Technology 37.54%
2 Communication Services 11.03%
3 Consumer Discretionary 10.09%
4 Healthcare 8.06%
5 Financials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUZ icon
601
Cousins Properties
CUZ
$4.83B
$239K ﹤0.01%
+7,961
New +$225K
FDS icon
602
Factset
FDS
$10.1B
$235K ﹤0.01%
526
RACE icon
603
Ferrari
RACE
$71.5B
$230K ﹤0.01%
469
SNA icon
604
Snap-on
SNA
$21.3B
$229K ﹤0.01%
735
+4
+0.5% +$1.27K
ACAD icon
605
Acadia Pharmaceuticals
ACAD
$5.06B
$229K ﹤0.01%
10,596
CELC icon
606
Celcuity
CELC
$4.43B
$227K ﹤0.01%
17,011
+1,392
+9% +$15.2K
NTLA icon
607
Intellia Therapeutics
NTLA
$1.68B
$226K ﹤0.01%
24,053
-2,484
-9% -$20.4K
ZBRA icon
608
Zebra Technologies
ZBRA
$17.9B
$219K ﹤0.01%
+711
New +$193K
DPZ icon
609
Domino's
DPZ
$11.5B
$218K ﹤0.01%
484
DNLI icon
610
Denali Therapeutics
DNLI
$4B
$212K ﹤0.01%
15,174
SBRA icon
611
Sabra Healthcare REIT
SBRA
$5.28B
$207K ﹤0.01%
+11,219
New +$199K
COLD icon
612
Americold
COLD
$4.17B
$207K ﹤0.01%
+12,423
New +$225K
EG icon
613
Everest Group
EG
$14.2B
$204K ﹤0.01%
601
RCKT icon
614
Rocket Pharmaceuticals
RCKT
$397M
$78.5K ﹤0.01%
32,030
-4,833
-13% -$24.5K
TALK icon
615
Talkspace
TALK
$878M
$77.4K ﹤0.01%
27,834
VYGR icon
616
Voyager Therapeutics
VYGR
$195M
$46.5K ﹤0.01%
14,960
BPMC
617
DELISTED
Blueprint Medicines
BPMC
-20,972
Closed -$1.86M
DCI icon
618
Donaldson
DCI
$11.2B
-11,848
Closed -$795K
DFS
619
DELISTED
Discover Financial Services
DFS
-17,848
Closed -$3.05M
JAZZ icon
620
Jazz Pharmaceuticals
JAZZ
$16.7B
-1,672
Closed -$208K
LNTH icon
621
Lantheus
LNTH
$6.59B
-4,329
Closed -$423K
MDB icon
622
MongoDB
MDB
$33.5B
-4,467
Closed -$784K
ORIC icon
623
Oric Pharmaceuticals
ORIC
$1.41B
-40,934
Closed -$228K
WCC
624
WESCO International
WCC
$17.9B
-24,991
Closed -$3.88M
XENE icon
625
Xenon Pharmaceuticals
XENE
$6.21B
-6,111
Closed -$205K

Similar funds

NEOS Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, NEOS Investment Management held 626 positions worth $8.08B, up 53% from $5.27B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

NEOS Investment Management deployed $1.98B of net new capital in Q2 2025, opening 29 new positions and adding to 518 existing holdings. Its largest new stake was Shopify: 206,686 shares worth $23.8M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Vulcan Materials, an estimated $4.18M trimmed.

  • NEOS Investment Management's largest Q2 2025 buy was Shopify: 206,686 shares worth $23.8M.
  • NEOS Investment Management added most to Microsoft in Q2 2025, an estimated $142M increase.
  • NEOS Investment Management's biggest Q2 2025 reduction was Vulcan Materials, cutting an estimated $4.18M.
  • NEOS Investment Management fully exited WESCO International in Q2 2025, selling an estimated $3.88M.
  • NEOS Investment Management's ten largest holdings make up 38% of its $8.08B portfolio in Q2 2025.
  • NEOS Investment Management opened 29 new positions and closed 10 in Q2 2025.
  • NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $8.08B.

Based on NEOS Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.